Impact of Blood Pressure Measurement Methods for the Prediction of Intracranial Hemorrhage After Thrombectomy in Acute Stroke
概览
- 阶段
- 不适用
- 干预措施
- Clearsight device (Edwards) around the finger
- 疾病 / 适应症
- Acute Stroke
- 发起方
- Fondation Ophtalmologique Adolphe de Rothschild
- 入组人数
- 455
- 试验地点
- 2
- 主要终点
- Occurence of intracranial hemorrhagic complications
- 状态
- 已完成
- 最后更新
- 23天前
概览
简要总结
A monocentric, non-randomized, prospective study in which each patient is his/her own control.
The study investigates 2 methods of blood pressure measurement, within the first 24 hours after reperfusion, i) Continuous measurement of blood pressure with the Clearsight device (Edwards) and ii) intermittent blood pressure measurements with cuff.
详细描述
Patients will be followed for 72 hours: * inclusion after reperfusion: clinical evaluation with NIHSS (National Institute of Health Stroke Score) score, measurement of blood pressure. * within 24 hours after reperfusion: blood pressure measurements * at 24 hours: NIHSS score. * Between 24 and 36 hours :cerebral scan (assessment of hemorrhagic transformations and cerebral infarction volumes). * 72 hours after reperfusion: brain scanner in case of hyperdensity on the initial scanner
研究者
入排标准
入选标准
- •Patient aged 18 years or older
- •Treated for occlusion of the internal carotid arteries and/or proximal middle cerebral arteries (M1 and M2 segments), vertebral artery, and/or basilar artery
- •Affiliated with or beneficiary of a Social Security plan
- •Having received informed information about the study and having given consent to participate in the study
排除标准
- •Per-procedure hemorrhagic complications (before reperfusion is achieved)
- •Patient benefiting from legal protection measures
- •Pregnant or breastfeeding women
研究组 & 干预措施
Two measuring methods of blood pressure
干预措施: Clearsight device (Edwards) around the finger
Two measuring methods of blood pressure
干预措施: Intermittent blood pressure measurements with cuff.
结局指标
主要结局
Occurence of intracranial hemorrhagic complications
时间窗: 36 hours after baseline
number of intracranial hemorrhagic complications (symptomatic or asymptomatic) on brain scanner, evaluated with a double centralized blind reading